A pediatric neurologist that understands the connection between CFD and ASD and how to treat it
This metabolic adaptation utilizes the spare capacity of mitochondria to fulfill increasing energy demands
Nosseir NS, Ali MHM, Ebaid HM
Wegovy is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed for weight management in adults with obesity or overweight with weight-related comorbidities, and in adolescents aged 12 years and above in certain circumstances
However, once these patents expire, generic manufacturers could enter the market relatively quickly, as the synthesis of a small molecule like orforglipron does not require the specialized SPPS facilities and expertise needed for generic peptide production
The Lancet Diabetes & Endocrinology , 11(4), 250262